Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 8, 2011

Primary Completion Date

September 10, 2013

Study Completion Date

September 10, 2013

Conditions

Reduction in Severity of Skin Scarring

Interventions

DRUG

EXC 001 (currently called PF-06473871)

Single dose administered by injection at four different times

Trial Locations (4)

Altus Research, Lake Worth

Northwestern University,Division of Plastic Surgery, Chicago

Connall Consmetic Surgery, Tualatin

Jewell Plastic Surgery Center, Eugene